Medpace Voice

Medpace is proud to welcome Dr. Jack Bleesing, an accomplished immunologist and board-certified physician-scientist, with 20+ years of experience to...

As a Hematologist/Oncologist, I have always been a life-long advocate of the rigor and structure of a clinical trial. That...

Medpace oncology experts examine the clinical and operational concepts driving the next phase of oncology development presented at 2025 ASCO.

As biopharmaceutical companies seek to optimize clinical trial design, accelerate regulatory approvals, and improve patient outcomes, insights from JSMO 2025 provide a critical foundation for…

Every cancer journey is unique—shaped by the individual, the disease, and the evolving landscape of treatment.

ASH 2024 Highlights:
Advancing Therapeutic Scalability, Precision Medicine, and Next-Gen Trial Designs

Breast cancer persists as a critical global health challenge, with an estimated 1 in 8 women facing a diagnosis over...

Upon their return from ESMO Congress 2024 and in recognition of World Cancer Research Day, Medpace oncology experts identified three...

Explore insights from Medpace oncology experts as they identify several of the latest innovations in hematologic and oncologic research shared at ASCO 2024.

Medpace is pleased to announce the addition of new Oncology expert, Dr. Amanda Goldrick, to the Medical Leadership team.